November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
The first edition of the I.N.N.O.V.A.T.E – Neoadjuvant immunotherapy across cancers – 3P Solutions
May 11, 2024, 10:58

The first edition of the I.N.N.O.V.A.T.E – Neoadjuvant immunotherapy across cancers – 3P Solutions

3P Solutionย shared a post on LinkedIn:

โ€œREGISTRATION IS NOW OPEN!

The first edition of the ๐—œ.๐—ก.๐—ก.๐—ข.๐—ฉ๐—”.๐—ง.๐—˜. – ๐—ก๐—ฒ๐—ผ๐—ฎ๐—ฑ๐—ท๐˜‚๐˜ƒ๐—ฎ๐—ป๐˜ ๐—ถ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—ฎ๐—ฐ๐—ฟ๐—ผ๐˜€๐˜€ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ๐˜€ – will take place in ๐—ก๐—ฎ๐—ฝ๐—น๐—ฒ๐˜€ on ๐—๐˜‚๐—น๐˜† ๐Ÿญ๐Ÿญ๐˜๐—ต ๐—ฎ๐—ป๐—ฑ ๐Ÿญ๐Ÿฎ๐˜๐—ต. ๐—•๐—ผ๐—ผ๐—ธ ๐˜†๐—ผ๐˜‚๐—ฟ ๐˜€๐—ฝ๐—ผ๐˜ ๐—ป๐—ผ๐˜„, ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜! All you need to do is sending an ๐—ฒ-๐—บ๐—ฎ๐—ถ๐—น with your request (please include your name, surname and the name of your institution) to the following address: ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป@๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ฒ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ.๐—ผ๐—ฟ๐—ด.

๐—ง๐—ต๐—ฒ ๐—œ.๐—ก.๐—ก.๐—ข.๐—ฉ๐—”.๐—ง.๐—˜. ๐—ฐ๐—ผ๐—ป๐—ด๐—ฟ๐—ฒ๐˜€๐˜€ features invited speakers, ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐˜๐˜€ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฎ๐—ฟ๐—ผ๐˜‚๐—ป๐—ฑ ๐˜๐—ต๐—ฒ ๐˜„๐—ผ๐—ฟ๐—น๐—ฑ, and panel discussions on a variety of topics. This will include disease specific field overviews, pathology, biomarkers, imaging and patient reported outcomes.

๐˜ฟ๐™ค๐™ฃโ€™๐™ฉ ๐™ข๐™ž๐™จ๐™จ ๐™ž๐™ฉ!

Thanks to the Presidency: Paolo A. Ascierto, Prof Dr Christian Blank, Liz Burton.”

Source:ย 3P Solution/LinkedIn